Who Owns GSK plc
Every manager with more than $100m in listed equities files a 13F each quarter naming what they hold. These are the ones reporting a position in GSK plc.
Who crossed 5% of GSK →Positions as of 2026-09-30
Largest first. The move is against the previous quarter that manager filed, not the previous calendar quarter.
| Manager | Value |
|---|---|
| Douglas Lane & Associates, LLCCOMMON749.7K shtrimmed | $36.1M |
| Sound Income Strategies, LLCSPONSORED ADR348.3K shadded | $16.2M |
| Keystone Financial Planning, Inc.SPONSORED ADR211.2K shadded | $10.2M |
| BONNESS ENTERPRISES INCSPONSORED ADR41.5K shheld | $2M |
| Farther Finance Advisors, LLCADR40.6K shadded | $2M |
| Investors Research CorpSPONSORED ADR14.3K shtrimmed | $690.1K |
| Central Pacific Bank - Trust DivisionSPONSORED ADR12.6K shtrimmed | $605K |
| GAMMA Investing LLCCommon Stock12.3K shadded | $591.8K |
| ROCKLAND TRUST COSPONSORED ADR12.1K shtrimmed | $584.6K |
| Valeo Financial Advisors, LLCADR11.1K shadded | $536.8K |
| MOODY NATIONAL BANK TRUST DIVISIONSPONSORED ADR10.3K shadded | $495.1K |
| HF Advisory Group, LLCSPONSORED ADR8.1K shadded | $389.4K |
| M.E. ALLISON & CO., INC.SPONSORED ADR7K shheld | $338K |
| CANANDAIGUA NATIONAL BANK & TRUST COCom6.2K shadded | $297.9K |
| Grove Bank & TrustSPONSORED ADR5.9K shadded | $282.2K |
| Venture Visionary Partners LLCSPONSORED ADR5.4K shadded | $260.5K |
| Shulman DeMeo Asset Management LLCSPONSORED ADR5.6K shtrimmed | $260K |
| Monument Capital ManagementSPONSORED ADR5.2K shtrimmed | $249.7K |
| Peoples Bank/KSInt'l Common Stock5K shheld | $242.3K |
| Wedmont Private CapitalSPONSORED ADR4.3K shadded | $201.3K |
| CoreCap Advisors, LLCADR2.9K shtrimmed | $137.4K |
| EASTERN BANKSPONSORED ADR2.8K shadded | $133.7K |
| Rosenberg Matthew HamiltonADR2.3K shheld | $112K |
| Bank & Trust CoSPONSORED ADR1.9K shheld | $90.5K |
| VALLEY WEALTH MANAGERS, INC.ADR1.5K shheld | $72.6K |
| STEPH & COSPONSORED ADR583 shadded | $28.1K |
| Retirement Wealth Solutions LLCSPONSORED ADR194 shtrimmed | $9.3K |
| ELEVATION WEALTH PARTNERS, LLCSPONSORED ADR164 shheld | $7.9K |
| Bank of New HampshireSPONSORED ADR160 sh— | $7.7K |
| GK Wealth Management LLCSPONSORED ADR145 sh— | $7K |
| TOMPKINS FINANCIAL CORPSPONSORED ADR100 shheld | $4.8K |
| TOTH FINANCIAL ADVISORY CORPSPONSORED ADR97 shadded | $4.7K |
| Bangor Savings BankSPONSORED ADR57 shheld | $2.7K |
| Bullock Wealth Management GroupADR53 shheld | $2.5K |
| GILPIN WEALTH MANAGEMENT, LLCSPONSORED ADR9 shtrimmed | $434 |
| Trust CoADR5 shtrimmed | $241 |
Source: quarterly 13F filings, via EDGAR. A 13F reports positions by CUSIP alone; each CUSIP here has been confirmed against OpenFIGI rather than matched by name, because a name match would attribute one company's shareholders to another. Positions are as of quarter end and can be months old by the time they are filed, and 13F covers long equity positions only — not shorts, and not most debt. The summed value is what these filers reported, not the company's institutional ownership.
More on GSK
Follow GSK plc (GSK) by email
New trades in GSK plc (GSK) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.